The AHA, Association of American Medical Colleges, America’s Essential Hospitals, Eastern Maine Healthcare Systems, Henry Ford Health System and Adventist Health System's Park Ridge Health yesterday urged a federal appeals court to find that they are entitled to a preliminary injunction in their lawsuit to prevent a nearly 30% Medicare payment reduction for many hospitals in the 340B drug savings program. In their brief, they seek remand of this case back to the trial court with a specific instruction from the appeals court to enter the injunction. At a minimum, the injunction would direct the Department of Health and Human Services to set outpatient prospective payment system payment rates for calendar year 2019 without the nearly 30% reduction and at the level needed to correct the past effects of the reduction. The lower court on Dec. 29 dismissed the lawsuit as premature, without ruling on the merits of the groups’ claim that the HHS Secretary exceeded his statutory authority in making the payment reduction. Today’s filing concludes all briefing in the appeal. The court has scheduled oral arguments for May 4.  
 

Related News Articles

Headline
The Centers for Disease Control and Prevention Sept. 18 issued a health advisory on a new outbreak of Ebola in the Democratic Republic of the Congo. There are…
Headline
The Centers for Medicare & Medicaid Services Sept. 18 released a final rule on policy and technical changes to Medicare Advantage, the Medicare…
Headline
The Senate Sept. 19 failed to adopt a continuing resolution by a 44-48 vote  that would have funded the government through Nov. 21. The CR was passed by…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Perspective
Public
All of America’s hospitals and health systems, regardless of ownership status, size or location, provide a vast range of benefits, programs and essential…
Headline
The Food and Drug Administration released a final rule Sept. 18 that rescinds one from 2024 that applied medical device rules to laboratory-developed tests.…